| 引用本文: |
黄明明, 谢虹亭, 刘泽豪, 薛鹏, 朱世杰.基于“毒损络脉”探究EphA2与肺癌的因果关联:一项两样本双向孟德尔随机化研究[J].湖南中医药大学学报,2026,46(10):2092-2099[点击复制] |
|
| |
|
|
| 本文已被:浏览 245次 下载 506次 |
| 基于“毒损络脉”探究EphA2与肺癌的因果关联:一项两样本双向孟德尔随机化研究 |
| 黄明明,谢虹亭,刘泽豪,薛鹏,朱世杰 |
| (北京中医药大学房山医院, 北京 102400;中国中医科学院望京医院肿瘤科, 北京 100102) |
| 摘要: |
| 目的 基于中医学“毒损络脉”理论,探讨受体酪氨酸激酶肝配蛋白A型受体2(EphA2)与肺癌之间的因果关联。方法 采用两样本双向孟德尔随机化(MR)方法,整合全基因组关联研究数据库,选取与EphA2蛋白水平显著相关的单核苷酸多态性作为工具变量,主要采用逆方差加权法(IVW)评估因果效应,辅以MR-Egger回归法、加权众数法、加权中位数法及简单众数法等方法进行验证,并进行异质性、多效性及敏感性分析。结果 正向MR分析显示,遗传预测的EphA2高表达会增加肺癌发病的风险(ieu-a-966数据集:OR=1.219,95%CI:1.034~1.438,P=0.019)。反向MR分析中,ieu-a-987数据集IVW结果未达到统计学显著水平(OR=1.035,95%CI:0.998~1.074,P=0.059),不同阈值下敏感性分析结论一致。敏感性分析与异质性来源探查均未发现明显的水平多效性或影响结论稳健性的偏倚。结论 本研究为EphA2可能增加肺癌风险提供遗传学证据,反向分析尚未获得肺癌影响EphA2的显著因果证据,仍需进一步验证。该发现将“癌毒壅滞、损络成积”的生物学基础与EphA2相联系,丰富了“毒损络脉”的理论内涵,为中医药防治肺癌提供了新的思路与方向。 |
| 关键词: 毒损络脉|受体酪氨酸激酶肝配蛋白A型受体2|肺癌|孟德尔随机化|癌毒 |
| DOI:10.3969/j.issn.1674-070X.2026.10.015 |
| 投稿时间:2025-12-15 |
| 基金项目:国家自然科学基金项目(82505692,82575164);中国中医科学院高水平中医医院建设项目(WJZJ-202305)。 |
|
| Causal association between EphA2 and lung cancer from the perspective of "toxic pathogens damaging the collaterals": a two-sample bidirectional Mendelian randomization study |
| HUANG Mingming, XIE Hongting, LIU Zehao, XUE Peng, ZHU Shijie |
| (Fangshan Hospital, Beijing University of Chinese Medicine, Beijing 102400, China;Department of Oncology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China) |
| Abstract: |
| Objective To investigate the causal association between ephrin type-A receptor 2 (EphA2), a receptor tyrosine kinase, and lung cancer from the perspective of the Chinese medicine theory of "toxic pathogens damaging the collaterals." Methods A two-sample bidirectional Mendelian randomization (MR) analysis was conducted using summary statistics from genome-wide association study (GWAS) databases. Single-nucleotide polymorphisms (SNPs) significantly associated with EphA2 protein levels were selected as instrumental variables. The inverse-variance weighted (IVW) method was used as the primary method to estimate causal effects, supplemented by MR-Egger regression, weighted mode, weighted median, and simple-mode methods. Heterogeneity, horizontal pleiotropy, and sensitivity analyses were also performed. Results Forward MR analysis showed that genetically predicted higher EphA2 protein levels were associated with an increased risk of lung cancer in the ieu-a-966 dataset (OR=1.219, 95% CI: 1.034~1.438, P=0.019). In the reverse MR analysis, the IVW estimate for the ieu-a-987 dataset did not reach statistical significance (OR=1.035, 95% CI: 0.998~1.074, P=0.059), and the results of sensitivity analyses were consistent across different thresholds. Sensitivity analyses and assessments of the sources of heterogeneity revealed no evidence of substantial horizontal pleiotropy or bias that could compromise the robustness of the findings. Conclusion This study provides genetic evidence suggesting that higher EphA2 protein levels may increase the risk of lung cancer. Reverse MR analysis did not provide statistically significant evidence that lung cancer causally affects EphA2 levels; therefore, further validation is required. These findings link EphA2 to the biological basis of the concept that "cancer toxin accumulates and stagnates, thereby damaging the collaterals and giving rise to masses," thereby enriching the theoretical implications of "toxic pathogens damaging the collaterals" and providing new insights and directions into the prevention and treatment of lung cancer with Chinese medicine. |
| Key words: toxic pathogens damaging the collaterals|ephrin type-A receptor 2|lung cancer|Mendelian randomization|cancer toxin |
|
 二维码(扫一下试试看!) |
|
|
|
|